Jong Hee Lee, Ha-Eun Ryu, Taehwa Han, Byoungjin Park, Seok-Jae Heo, Yu-Jin Kwon
{"title":"与代谢功能障碍相关的脂肪变性肝病相关的饮食和生活方式因素的聚类分析:来自韩国基因组和流行病学研究的发现","authors":"Jong Hee Lee, Ha-Eun Ryu, Taehwa Han, Byoungjin Park, Seok-Jae Heo, Yu-Jin Kwon","doi":"10.1007/s12020-025-04200-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>As the global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to increase, its early detection is crucial. We investigated the combined effects of various factors on MASLD development to enhance the understanding of individuals at high risk of MASLD.</p><p><strong>Methods: </strong>A total of 4670 participants from the Korean Genome and Epidemiology Study were included. Cluster analysis and Cox proportional hazards regression were conducted to identify distinct risk factor clusters and evaluate their association with MASLD incidence.</p><p><strong>Results: </strong>Four clusters were identified based on lifestyle characteristics: Cluster 1 (LA)-low activity, Cluster 2 (HPF)-lowest carbohydrate intake with high protein and fat intake, Cluster 3 (HC)-highest carbohydrate intake with low protein and fat intake, and Cluster 4 (ASC)-highest alcohol consumption and smoking levels. Cluster 4 (ASC) exhibited the highest cumulative incidence of MASLD, followed by Cluster 3 (HC). Compared to Clusters 1, 2, and 3, Cluster 4 (ASC) had significantly higher hazard ratios (HRs) for MASLD incidence (HR: 1.35 [95% confidence interval {CI}: 1.19-1.53]; p < 0.001, HR: 1.31 [95% CI: 1.14-1.50]; p < 0.001, and HR: 1.22 [95% CI: 1.07-1.38]; p = 0.002, respectively).</p><p><strong>Conclusion: </strong>Clusters exhibiting various risk factor phenotypes were identified, and smoking, alcohol consumption, and carbohydrate intake were significantly associated with a higher risk of MASLD. Our findings support the importance of early screening and personalized approaches for individuals at high risk of MASLD.</p>","PeriodicalId":11572,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study.\",\"authors\":\"Jong Hee Lee, Ha-Eun Ryu, Taehwa Han, Byoungjin Park, Seok-Jae Heo, Yu-Jin Kwon\",\"doi\":\"10.1007/s12020-025-04200-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>As the global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to increase, its early detection is crucial. We investigated the combined effects of various factors on MASLD development to enhance the understanding of individuals at high risk of MASLD.</p><p><strong>Methods: </strong>A total of 4670 participants from the Korean Genome and Epidemiology Study were included. Cluster analysis and Cox proportional hazards regression were conducted to identify distinct risk factor clusters and evaluate their association with MASLD incidence.</p><p><strong>Results: </strong>Four clusters were identified based on lifestyle characteristics: Cluster 1 (LA)-low activity, Cluster 2 (HPF)-lowest carbohydrate intake with high protein and fat intake, Cluster 3 (HC)-highest carbohydrate intake with low protein and fat intake, and Cluster 4 (ASC)-highest alcohol consumption and smoking levels. Cluster 4 (ASC) exhibited the highest cumulative incidence of MASLD, followed by Cluster 3 (HC). Compared to Clusters 1, 2, and 3, Cluster 4 (ASC) had significantly higher hazard ratios (HRs) for MASLD incidence (HR: 1.35 [95% confidence interval {CI}: 1.19-1.53]; p < 0.001, HR: 1.31 [95% CI: 1.14-1.50]; p < 0.001, and HR: 1.22 [95% CI: 1.07-1.38]; p = 0.002, respectively).</p><p><strong>Conclusion: </strong>Clusters exhibiting various risk factor phenotypes were identified, and smoking, alcohol consumption, and carbohydrate intake were significantly associated with a higher risk of MASLD. Our findings support the importance of early screening and personalized approaches for individuals at high risk of MASLD.</p>\",\"PeriodicalId\":11572,\"journal\":{\"name\":\"Endocrine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12020-025-04200-3\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04200-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study.
Purpose: As the global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to increase, its early detection is crucial. We investigated the combined effects of various factors on MASLD development to enhance the understanding of individuals at high risk of MASLD.
Methods: A total of 4670 participants from the Korean Genome and Epidemiology Study were included. Cluster analysis and Cox proportional hazards regression were conducted to identify distinct risk factor clusters and evaluate their association with MASLD incidence.
Results: Four clusters were identified based on lifestyle characteristics: Cluster 1 (LA)-low activity, Cluster 2 (HPF)-lowest carbohydrate intake with high protein and fat intake, Cluster 3 (HC)-highest carbohydrate intake with low protein and fat intake, and Cluster 4 (ASC)-highest alcohol consumption and smoking levels. Cluster 4 (ASC) exhibited the highest cumulative incidence of MASLD, followed by Cluster 3 (HC). Compared to Clusters 1, 2, and 3, Cluster 4 (ASC) had significantly higher hazard ratios (HRs) for MASLD incidence (HR: 1.35 [95% confidence interval {CI}: 1.19-1.53]; p < 0.001, HR: 1.31 [95% CI: 1.14-1.50]; p < 0.001, and HR: 1.22 [95% CI: 1.07-1.38]; p = 0.002, respectively).
Conclusion: Clusters exhibiting various risk factor phenotypes were identified, and smoking, alcohol consumption, and carbohydrate intake were significantly associated with a higher risk of MASLD. Our findings support the importance of early screening and personalized approaches for individuals at high risk of MASLD.
期刊介绍:
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.